ALEC
Price
$2.12
Change
-$0.09 (-4.07%)
Updated
Sep 15, 10:51 AM (EDT)
Capitalization
247.88M
56 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.08
Change
-$0.11 (-3.45%)
Updated
Sep 15, 12:06 PM (EDT)
Capitalization
196.56M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALEC vs VYGR

ALEC vs VYGR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALEC vs. VYGR commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and VYGR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($248M) has a higher market cap than VYGR($197M). ALEC YTD gains are higher at: 41.667 vs. VYGR (-18.830). VYGR (-113.37M) and ALEC (-117.76M) have comparable annual earnings (EBITDA) . ALEC has more cash in the bank: 173M vs. VYGR (116M). VYGR (32.6M) and ALEC (32.8M) have identical debt. VYGR has higher revenues than ALEC: VYGR (34.5M) vs ALEC (13.9M).
ALECVYGRALEC / VYGR
Capitalization248M197M126%
EBITDA-117.76M-113.37M104%
Gain YTD41.667-18.830-221%
P/E RatioN/A6.00-
Revenue13.9M34.5M40%
Total Cash173M116M149%
Total Debt32.8M32.6M101%
FUNDAMENTALS RATINGS
ALEC vs VYGR: Fundamental Ratings
ALEC
VYGR
OUTLOOK RATING
1..100
8980
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4772
P/E GROWTH RATING
1..100
917
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (56) in the Biotechnology industry is in the same range as ALEC (77). This means that VYGR’s stock grew similarly to ALEC’s over the last 12 months.

VYGR's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as ALEC (100). This means that VYGR’s stock grew similarly to ALEC’s over the last 12 months.

VYGR's SMR Rating (98) in the Biotechnology industry is in the same range as ALEC (100). This means that VYGR’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (47) in the Biotechnology industry is in the same range as VYGR (72). This means that ALEC’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for ALEC (91). This means that VYGR’s stock grew significantly faster than ALEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECVYGR
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 22 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (ALEC: $2.21 vs. VYGR: $3.19)
Brand notoriety: ALEC and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 172% vs. VYGR: 62%
Market capitalization -- ALEC: $247.88M vs. VYGR: $196.56M
ALEC [@Biotechnology] is valued at $247.88M. VYGR’s [@Biotechnology] market capitalization is $196.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green while VYGR’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 5 bearish.
  • VYGR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а -10.16% price change this week, while VYGR (@Biotechnology) price change was -9.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 10, 2026.

VYGR is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALEC
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEQFX19.53N/A
N/A
AMG River Road Large Cap Value Select I
SAPYX36.81N/A
N/A
ClearBridge Appreciation I
FZAMX29.56N/A
N/A
Fidelity Advisor Mid Cap II Z
LICSX20.65N/A
N/A
Lord Abbett International Equity R4
RTDTX14.92-0.06
-0.40%
Russell Inv Multifactor US Equity M

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with ARCT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+3.27%
ARCT - ALEC
62%
Loosely correlated
+3.80%
EDIT - ALEC
41%
Loosely correlated
+1.48%
CRBU - ALEC
40%
Loosely correlated
+1.57%
VYGR - ALEC
38%
Loosely correlated
N/A
BCYC - ALEC
36%
Loosely correlated
+0.78%
More